Quince Therapeutics to Participate at Upcoming Investor Conferences
15 10월 2024 - 5:05AM
Business Wire
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage
biotechnology company dedicated to unlocking the power of a
patient’s own biology for the treatment of rare diseases, today
announced that management will present at three upcoming investor
conferences:
- 2024 Maxim Healthcare Virtual Summit – Quince’s Chief Executive
Officer and Chief Medical Officer Dirk Thye, M.D., will participate
in a fireside chat on Thursday, October 17, 2024 beginning at 3:00
p.m. Eastern Time. Qualified investors can register here to access
the live event.
- LD Micro Main Event XVII – Quince’s Chief Operating Officer and
Chief Business Officer Brendan Hannah will present a company
overview on Tuesday, October 29, 2024 beginning at 6:30 p.m.
Eastern Time. Please register here to access the live
presentation.
- The ThinkEquity Conference 2024 – Quince’s President Charles
Ryan, J.D., Ph.D., will present a company overview on October 30,
2024 beginning at 3:00 p.m. Eastern Time. A webcast of the
presentation will be accessible here on the Events page of Quince’s
Investor Relations website.
About Quince Therapeutics
Quince Therapeutics (Nasdaq: QNCX) is a late-stage biotechnology
company dedicated to unlocking the power of a patient’s own biology
for the treatment of rare diseases. For more information on the
company and its latest news, visit www.quincetx.com and follow
Quince Therapeutics on social media platforms LinkedIn, Facebook,
X, and YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241014846322/en/
Media & Investor Contact: Stacy Roughan Quince
Therapeutics, Inc. Vice President, Corporate Communications &
Investor Relations ir@quincetx.com
Quince Therapeutics (NASDAQ:QNCX)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Quince Therapeutics (NASDAQ:QNCX)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024